中国医学前沿杂志（电子版）
中國醫學前沿雜誌（電子版）
중국의학전연잡지（전자판）
CHINESE JOURNAL OF THE FRONTIERS OF MEDICAL SCIENCE(ELECTRONIC VERSION)
2014年
5期
154-156
,共3页
小儿肺炎%细菌学%耐药性%分析
小兒肺炎%細菌學%耐藥性%分析
소인폐염%세균학%내약성%분석
Pediatric pneumonia%Bacteriology%Drug resistance
目的：对本院2000例小儿肺炎细菌学及其耐药性进行分析。方法随机选择本院2011年10月至2013年8月收治的2000例小儿肺炎患儿。将其痰液制成标本，进行细菌学培养，测定其对药物的敏感性。结果①分离出G-杆菌占62.26%；G＋球菌占27.32%；真菌占10.42%；②对于G-杆菌致病性前5位为：肺炎克雷伯杆菌、大肠埃希杆菌、阴沟肠杆菌、鲍曼不动杆菌以及铜绿假单胞菌，占G-杆菌总数的90%；③对于G＋球菌致病性前5位为：金黄色葡萄球菌、表皮葡萄球菌、轻型链球菌、溶血性葡萄球菌以及肺炎链球菌；④对G-杆菌敏感度较高的药物分别为环丙沙星、奈替米星、哌拉西林、阿米卡星以及美洛培南；⑤对G＋球菌142株金黄色葡萄球菌敏感度较高的药物为青霉素、四环素、红霉素、庆大霉素以及氯林可霉素。对220株其他球菌耐药性较高的药物为：青霉素、苯唑西林、红霉素、庆大霉素以及喹诺酮二代。结论在临床诊治过程中，应明确患者的致病菌，使用合理、有效的抗生素。
目的：對本院2000例小兒肺炎細菌學及其耐藥性進行分析。方法隨機選擇本院2011年10月至2013年8月收治的2000例小兒肺炎患兒。將其痰液製成標本，進行細菌學培養，測定其對藥物的敏感性。結果①分離齣G-桿菌佔62.26%；G＋毬菌佔27.32%；真菌佔10.42%；②對于G-桿菌緻病性前5位為：肺炎剋雷伯桿菌、大腸埃希桿菌、陰溝腸桿菌、鮑曼不動桿菌以及銅綠假單胞菌，佔G-桿菌總數的90%；③對于G＋毬菌緻病性前5位為：金黃色葡萄毬菌、錶皮葡萄毬菌、輕型鏈毬菌、溶血性葡萄毬菌以及肺炎鏈毬菌；④對G-桿菌敏感度較高的藥物分彆為環丙沙星、奈替米星、哌拉西林、阿米卡星以及美洛培南；⑤對G＋毬菌142株金黃色葡萄毬菌敏感度較高的藥物為青黴素、四環素、紅黴素、慶大黴素以及氯林可黴素。對220株其他毬菌耐藥性較高的藥物為：青黴素、苯唑西林、紅黴素、慶大黴素以及喹諾酮二代。結論在臨床診治過程中，應明確患者的緻病菌，使用閤理、有效的抗生素。
목적：대본원2000례소인폐염세균학급기내약성진행분석。방법수궤선택본원2011년10월지2013년8월수치적2000례소인폐염환인。장기담액제성표본，진행세균학배양，측정기대약물적민감성。결과①분리출G-간균점62.26%；G＋구균점27.32%；진균점10.42%；②대우G-간균치병성전5위위：폐염극뢰백간균、대장애희간균、음구장간균、포만불동간균이급동록가단포균，점G-간균총수적90%；③대우G＋구균치병성전5위위：금황색포도구균、표피포도구균、경형련구균、용혈성포도구균이급폐염련구균；④대G-간균민감도교고적약물분별위배병사성、내체미성、고랍서림、아미잡성이급미락배남；⑤대G＋구균142주금황색포도구균민감도교고적약물위청매소、사배소、홍매소、경대매소이급록림가매소。대220주기타구균내약성교고적약물위：청매소、분서서림、홍매소、경대매소이급규낙동이대。결론재림상진치과정중，응명학환자적치병균，사용합리、유효적항생소。
ObjectiveTo analyze the bacteriology and drug resistance of pediatric pneumonia in our hospital. MethodsThere were 2000 cases of pediatric pneumonia in our hospital randomly selected from October 2011 to August 2013. The sputum specimens were made for bacterial culture and measurement of susceptibility testing of drugs.Results ①Gram-negative bacillus accounted for 62.26% of the pathogenic bacteria, gram-positive bacillus accounted for 27.32% and fungus accounted for 10.42%.②The top 5 pathogenicity of gram-negative bacillus were Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, Acinetobacter baumannii and Pseudomonas aeruginosa, accounting for 90% of the number of gram-negative bacillus.③The top 5 pathogenicity of gram-positive bacillus were Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis, Streptococcus pneumoniae and Staphylococcus haemolyticus.④The drugs gram-negative bacillus susceptible to included cipro-lfoxacin, netilmicin, piperacillin, amikacin and meropenem.⑤The drugs gram-positive Staphylococcus aureus susceptible to included penicillin, tetracycline, erythromycin, gentamicin and clindamycin, while for other cocci, the drugs included penicillin, oxacillin, erythromycin, gentamicin, and quinoloneⅡ.ConclusionIn the process of clinical diagnosis and treatment, we need to be clear of the pathogens and make use of antibiotics more reasonably and effectively.
